# Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy

> **NCT02011971** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Stanford University** · enrollment: 30 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Vinpocetine

## Key facts

- **NCT ID:** NCT02011971
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2012-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** We are now considering revision of the IND to determine maximum tolerated dose
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02011971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02011971, "Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02011971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*